Stockscreener 앱 받기
1.16
0.85%
-0.01
시장 영업 전:
1.15
-0.01
-0.86%
Vivani Medical Inc 주식(VANI)의 최신 뉴스
Comparing Precision Optics (NASDAQ:POCI) & Vivani Medical (NASDAQ:VANI) - Defense World
Vivani Medical, Inc. (NASDAQ:VANI) Short Interest Update - MarketBeat
Presenting on the Emerging Growth Conference 78 Day 2 on January 16 Register Now - GlobeNewswire Inc.
Geode Capital Management LLC Purchases 15,008 Shares of Vivani Medical, Inc. (NASDAQ:VANI) - Defense World
Reviewing CONMED (NYSE:CNMD) and Vivani Medical (NASDAQ:VANI) - Defense World
SABBY MANAGEMENT, LLC Acquires Additional Shares in Bluejay Diag - GuruFocus.com
Financial Contrast: Getinge AB (publ) (OTCMKTS:GNGBY) and Vivani Medical (NASDAQ:VANI) - Defense World
Vivani begins exenatide implant trial for obesity in Australia - Yahoo Finance
EXCLUSIVE: Vivani Medical Initiates First Human Clinical Trial With GLP-1 Implant For Weight Loss In Australia - AOL
Vivani Medical begins first human trial of implantable drug - Investing.com
Vivani Medical Announces Initiation of First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia - Business Wire
Vivani Medical to Present at the Innovation in Obesity Therapeutics Summit West Coast - Business Wire
Short Interest in Vivani Medical, Inc. (NASDAQ:VANI) Drops By 29.6% - MarketBeat
Financial Review: Vivani Medical (NASDAQ:VANI) vs. Heyu Biological Technology (OTCMKTS:HYBT) - Defense World
Independent Chairman of the Board of Vivani Medical Gregg Williams Buys 30% More Shares - Simply Wall St
Vivani Medical: Q3 Earnings Snapshot - Darien Times
Vivani Medical Reports Q3 Loss, Advances GLP-1 Trials - TipRanks
Vivani Medical, Inc. (NASDAQ:VANI) Director Gregg Williams Purchases 3,968,253 Shares - MarketBeat
Vivani medical director Gregg Williams buys $5 million in stock By Investing.com - Investing.com Nigeria
Vivani medical director Gregg Williams buys $5 million in stock - Investing.com India
Vivani Medical Secures Funding for GLP-1 Implant Trial - TipRanks
Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results - Business Wire
Vivani Medical (NASDAQ:VANI) Now Covered by HC Wainwright - Defense World
HC Wainwright & Co. Initiates Coverage of Vivani Medical (VANI) with Buy Recommendation - MSN
3 US Penny Stocks To Monitor In October 2024 - Simply Wall St
Vivani Medical to Present at the Partnership Opportunities in Drug Delivery (PODD) Event and ThinkEquity Conference in October 2024 - Business Wire
Vivani Medical's Market Cap Up US$6.6m Following Year Of Insider Stock Buying - Simply Wall St
Vivani Medical (NASDAQ:VANI) Shares Up 0.9%Here's Why - MarketBeat
Vivani Medical's chief business officer buys shares worth $2,835 - Investing.com India
Vivani Medical's chief business officer buys shares worth $2,835 By Investing.com - Investing.com Australia
Thursday's Insider Trading Moves: Top Buys and Sells in US Stocks - Investing.com India
Precision Optics (OTCMKTS:PEYE) & Vivani Medical (NASDAQ:VANI) Head-To-Head Analysis - Defense World
Vivani Medical (NASDAQ:VANI) Stock Quotes, Forecast and News Summary - Benzinga
Vivani Medical obtains Australian approval to begin GLP-1 implant trial - Yahoo Finance
Vivani Medical Receives Regulatory Approval to Initiate First in Human Clinical Trial with GLP-1 Implant in Obese and Overweight Individuals in Australia - BioSpace
Vivani Medical's implant trial gets Australian regulatory nod - Investing.com Australia
Vivani Medical's implant trial gets Australian regulatory nod By Investing.com - Investing.com Canada
Vivani Medical to Test Implant in Obese and Overweight Patients - Yahoo Finance
EXCLUSIVE: Vivani Medical Advances Its Obesity Treatment Implant With New Clinical Trial in Australia - Yahoo Finance
Ventyx deal a sign of Sanofi’s growing interest neuro-immunology? - BioCentury
Sanofi gains exclusivity rights to Ventyx’s CNS-penetrant drug in $27m deal - Yahoo! Voices
Ventyx stock climbs 8% on $27M Sanofi investment - MSN
Sanofi scoops negotiation rights to Ventyx obesity, Parkinson's candidate for $27M - Fierce Biotech
0.82%
0.53%
자본화:
|
볼륨(24시간):